The Recent “Tidal Wave” Of Vaccine News Is An Alert For Investors

Ashley Hayes

Published on: 24/08/2020

A “tidal wave” of COVID-19 vaccine news has hit the market in recent days – and is likely a prelude to many market-driving vaccine developments in the coming

FDAInvestingInvestorsJohnsonMarket-Driving Vaccine DevelopmentsPfzierVaccine NewsVaccine RaceCoronavirusCoronavirus PandemicCOVID-19 PandemicMedical StocksStock MarketStocks to Watch

The New Birth Control System That Could Shake Up The Contraceptives Market

Ashley Hayes

Published on: 16/08/2018

The FDA just approved a first-of-its-kind vaginal birth control system that is woman-controlled, procedure-free, long-acting and reversible. Here is the

Contraceptive MarketFDAHealth StocksInvestingInvestorMarket ChangesNew Chemical EntityStocksInvestingProfitable StocksStock MarketWomen Investors

Reconsider Bypassing These Biotechs

Ashley Hayes

Published on: 20/07/2018

These two biotech companies are big established players rather than exciting start-ups, which may help explain why they find themselves underappreciated by

Biotech CompaniesBiotech StocksCash FlowsFDAInvestorInvestorsPlayersStock MarketUnderappreciated InvestmentsMedical StocksProfitable StocksStock MarketStocks to WatchUndervalued StocksWomen Focused Medical Stock

Blockbuster Or Bust?

Ashley Hayes

Published on: 24/05/2018

Of the three marijuana-based drugs that have been approved by the FDA to date, none have been big commercial successes. In contrast, this cannabinoid drug

Annabinoid DrugFDAInvestmentInvestment StrategyInvestorMarijuana InvestmentMarijuana-Based DrugsMedical Marijuana InvestingMMJ InvestingMMJ StocksStock MarketMMJ StocksProfitable InvestmentsStock MarketStocks to Watch